IRMD vs PATH
Iradimed Co (IRMD) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Iradimed Co (IRMD) is a medical devices company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported IRMD revenue for 2024-12-31 was $73.2M. Net income was $19.2M. Revenue was up 11.7% from 2023-12-31 to 2024-12-31. IRMD currently screens at market cap $1.19B and trailing P/E 50.9.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
IRMD currently screens at market cap $1.19B and trailing P/E 50.9. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the IRMD and PATH stock pages for the full models.
Not investment advice.